Cargando…
Correction to: Setomimycin as a potential molecule for COVID‑19 target: in silico approach and in vitro validation
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422929/ https://www.ncbi.nlm.nih.gov/pubmed/36036846 http://dx.doi.org/10.1007/s11030-022-10488-4 |
| _version_ | 1784777919002836992 |
|---|---|
| author | Manhas, Ravi S. Tiwari, Harshita Noor, Mateen Ahmed, Ajaz Vishwakarma, Jyoti Tripathi, Raja B. M. Ramachandran, Ravishankar Madishetti, Sreedhar Mukherjee, Debaraj Nargotra, Amit Chaubey, Asha |
| author_facet | Manhas, Ravi S. Tiwari, Harshita Noor, Mateen Ahmed, Ajaz Vishwakarma, Jyoti Tripathi, Raja B. M. Ramachandran, Ravishankar Madishetti, Sreedhar Mukherjee, Debaraj Nargotra, Amit Chaubey, Asha |
| author_sort | Manhas, Ravi S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9422929 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94229292022-08-30 Correction to: Setomimycin as a potential molecule for COVID‑19 target: in silico approach and in vitro validation Manhas, Ravi S. Tiwari, Harshita Noor, Mateen Ahmed, Ajaz Vishwakarma, Jyoti Tripathi, Raja B. M. Ramachandran, Ravishankar Madishetti, Sreedhar Mukherjee, Debaraj Nargotra, Amit Chaubey, Asha Mol Divers Correction Springer International Publishing 2022-08-29 /pmc/articles/PMC9422929/ /pubmed/36036846 http://dx.doi.org/10.1007/s11030-022-10488-4 Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Correction Manhas, Ravi S. Tiwari, Harshita Noor, Mateen Ahmed, Ajaz Vishwakarma, Jyoti Tripathi, Raja B. M. Ramachandran, Ravishankar Madishetti, Sreedhar Mukherjee, Debaraj Nargotra, Amit Chaubey, Asha Correction to: Setomimycin as a potential molecule for COVID‑19 target: in silico approach and in vitro validation |
| title | Correction to: Setomimycin as a potential molecule for COVID‑19 target: in silico approach and in vitro validation |
| title_full | Correction to: Setomimycin as a potential molecule for COVID‑19 target: in silico approach and in vitro validation |
| title_fullStr | Correction to: Setomimycin as a potential molecule for COVID‑19 target: in silico approach and in vitro validation |
| title_full_unstemmed | Correction to: Setomimycin as a potential molecule for COVID‑19 target: in silico approach and in vitro validation |
| title_short | Correction to: Setomimycin as a potential molecule for COVID‑19 target: in silico approach and in vitro validation |
| title_sort | correction to: setomimycin as a potential molecule for covid‑19 target: in silico approach and in vitro validation |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422929/ https://www.ncbi.nlm.nih.gov/pubmed/36036846 http://dx.doi.org/10.1007/s11030-022-10488-4 |
| work_keys_str_mv | AT manhasravis correctiontosetomimycinasapotentialmoleculeforcovid19targetinsilicoapproachandinvitrovalidation AT tiwariharshita correctiontosetomimycinasapotentialmoleculeforcovid19targetinsilicoapproachandinvitrovalidation AT noormateen correctiontosetomimycinasapotentialmoleculeforcovid19targetinsilicoapproachandinvitrovalidation AT ahmedajaz correctiontosetomimycinasapotentialmoleculeforcovid19targetinsilicoapproachandinvitrovalidation AT vishwakarmajyoti correctiontosetomimycinasapotentialmoleculeforcovid19targetinsilicoapproachandinvitrovalidation AT tripathirajabm correctiontosetomimycinasapotentialmoleculeforcovid19targetinsilicoapproachandinvitrovalidation AT ramachandranravishankar correctiontosetomimycinasapotentialmoleculeforcovid19targetinsilicoapproachandinvitrovalidation AT madishettisreedhar correctiontosetomimycinasapotentialmoleculeforcovid19targetinsilicoapproachandinvitrovalidation AT mukherjeedebaraj correctiontosetomimycinasapotentialmoleculeforcovid19targetinsilicoapproachandinvitrovalidation AT nargotraamit correctiontosetomimycinasapotentialmoleculeforcovid19targetinsilicoapproachandinvitrovalidation AT chaubeyasha correctiontosetomimycinasapotentialmoleculeforcovid19targetinsilicoapproachandinvitrovalidation |